Secondary prevention in thrombotic antiphospholipid syndrome

被引：11
|
作者：
Pengo, V. [1 ]
Denas, G. [1 ]
Banzato, A. [1 ]
Bison, E. [1 ]
Bracco, A. [1 ]
Facchinetti, M. [2 ]
Hoxha, A. [2 ]
Ruffatti, A. [2 ]
机构：
[1] Univ Padua, Thrombosis Ctr, Dept Cardiac Thorac & Vasc Sci, I-35128 Padua, Italy
[2] Univ Padua, Rheumatol Unit, Dept Med, I-35128 Padua, Italy
来源：
LUPUS | 2012年 / 21卷 / 07期
关键词：
antiphospholipid; prevention; drugs; thrombosis; RECURRENT THROMBOSIS; THERAPY; INTENSITY; WARFARIN; RISK;
D O I：
10.1177/0961203312444773
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Secondary prevention of venous thromboembolism in antiphospholipid syndrome (APS) is usually made using vitamin K antagonists (VKAs) to maintain an international normalized ratio (INR) between 2.0 and 3.0. The optimal intensity of anticoagulation was determined in two prospective randomized controlled trials, both excluding the benefit of more intense anticoagulation. The same regimen is also recommended in patients with APS and arterial thromboembolism as aspirin does not appear to protect against recurrences. The duration of treatment is usually indefinite because of a substantial risk of recurrence. Lupus (2012) 21, 734-735.
引用
收藏
页码：734 / 735
页数：2
相关论文
共 50 条
  • [31] A PRIMARY THROMBOTIC SYNDROME - ABSENCE OF ANTIPHOSPHOLIPID ANTIBODIES
    SABBAGA, J
    NETO, JF
    CHADDAD, R
    CECCONELLO, I
    DEOLIVEIRA, RM
    CLINICAL RHEUMATOLOGY, 1991, 10 (01) : 81 - 83
  • [32] The Management of Stroke in Antiphospholipid Syndrome
    Panichpisal, Kessarin
    Rozner, Eduard
    Levine, Steven R.
    CURRENT RHEUMATOLOGY REPORTS, 2012, 14 (01) : 99 - 106
  • [33] What is the role of hydroxychloroquine in reducing thrombotic risk in patients with antiphospholipid antibodies?
    Wang, Tzu-Fei
    Lim, Wendy
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 714 - 716
  • [34] Progression of antiphospholipid antibody syndrome to catastrophic antiphospholipid antibody syndrome acutely with cessation of antithrombotic therapy
    Katikireddi, V. S.
    Kandiah, D. A.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (05) : 585 - 591
  • [35] Prevention of thrombosis in antiphospholipid syndrome
    Lim, Wendy
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 707 - 713
  • [36] PREVENTION OF MISCARRIAGE IN ANTIPHOSPHOLIPID SYNDROME
    PASSALEVA, A
    MASSAI, G
    DELIOS, MM
    LIVI, C
    ABBATE, R
    AUTOIMMUNITY, 1992, 14 (02) : 121 - 125
  • [37] Antiphospholipid syndrome
    Danowski, Adriana
    Levy, Roger A.
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2013, 53 (02) : 139 - 140
  • [38] How to treat patients with thrombotic antiphospholipid syndrome in 2024?
    Jurcut, Ciprian
    Caraiola, Simona
    Radin, Massimo
    Sciascia, Savino
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2024,
  • [39] Severe cutaneous necrosis in antiphospholipid syndrome
    Mostafa, Mariam
    Mahmoud, Amir
    Egiza, Hebat-Allah
    Niu, Chengu
    Elbahnasawy, Mohamed
    Yusuf, Yasmin
    Kouides, Peter
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (11) : E328 - E333
  • [40] A rare combination of thrombotic thrombocytopenic purpura and antiphospholipid syndrome
    Viner, Maya
    Murakhovskaya, Irina
    BLOOD COAGULATION & FIBRINOLYSIS, 2017, 28 (05) : 411 - 415
12345